Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $360,168 - $423,337
-34,900 Reduced 32.11%
73,800 $856,000
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $277,380 - $331,752
27,600 Added 34.03%
108,700 $1.16 Million
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $83,398 - $100,122
7,400 Added 10.04%
81,100 $968,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $171,892 - $212,660
19,600 Added 36.23%
73,700 $798,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $466,074 - $551,610
48,600 Added 883.64%
54,100 $533,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $805,486 - $918,896
-89,300 Reduced 94.2%
5,500 $54,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $560,280 - $746,634
-60,900 Reduced 39.11%
94,800 $911,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $4.61 Million - $6.12 Million
-529,000 Reduced 77.26%
155,700 $1.73 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $4.39 Million - $5.76 Million
517,900 Added 310.49%
684,700 $5.83 Million
Q2 2022

Aug 08, 2022

BUY
$9.95 - $12.27 $437,799 - $539,880
44,000 Added 35.83%
166,800 $1.75 Million
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $677,871 - $1.06 Million
-69,100 Reduced 36.01%
122,800 $1.34 Million
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $5.39 Million - $6.55 Million
-446,100 Reduced 69.92%
191,900 $2.6 Million
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $5.89 Million - $6.72 Million
444,200 Added 229.21%
638,000 $8.65 Million
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $1.66 Million - $2.07 Million
128,000 Added 194.53%
193,800 $2.77 Million
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $417,865 - $570,067
-30,748 Reduced 31.85%
65,800 $919,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $1.38 Million - $1.81 Million
96,548 New
96,548 $1.81 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.